Alpana P Shukla

12PUBLICATIONS
12CO-AUTHORS
Aboriginal and Torres Strait Islander sport and physical activityFood technologyCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 04, 2025
Improved health-related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT-5 trial.

Alpana P Shukla, Julia P Dunn, Elisa Gomez Valderas

|Dec 17, 2024
Carbohydrates-Last Food Order Improves Time in Range and Reduces Glycemic Variability.

Samir Touhamy Ii, Kathyayini Palepu, Ampadi Karan

|Feb 22, 2023
Five-year Weight Loss Maintenance With Obesity Pharmacotherapy.

Michael A Weintraub, Debra D'Angelo, Beverly G Tchang

|Oct 14, 2022
Medical weight management protects against weight gain during the COVID-19 pandemic.

Sarah R Barenbaum, Katherine H Saunders, Karina M Chan

|Oct 06, 2022
Tirzepatide: Does the Evidence to Date Show Potential for the Treatment of Early Stage Type 2 Diabetes?

Tanzila S Razzaki, Alyson Weiner, Alpana P Shukla

|Jun 06, 2022
Long-term weight loss maintenance with obesity pharmacotherapy: A retrospective cohort study.

Beverly G Tchang, Mohini Aras, Alan Wu

Pageof 2